Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Spyral InSight Study

NCT: NCT07013929 · RECRUITING

NCT IDNCT07013929
StatusRECRUITING
Start Date2025-06-09
Completion2027-07-01

Brief Summary

The purpose of the Spyral InSight Early Clinical Feasibility Study is to characterize the physiological response to renal nerve stimulation (RNS) in humans prior to and post renal denervation.

Frequently Asked Questions

What is Spyral InSight Study?

Spyral InSight Study is a clinical trial registered under NCT07013929. Current status: RECRUITING.

What is the status of NCT07013929?

The current status of NCT07013929 (Spyral InSight Study) is: RECRUITING.

When did Spyral InSight Study start?

Spyral InSight Study started on 2025-06-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑